BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hassan N, Greve B, Espinoza-Sánchez NA, Götte M. Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer. Cell Signal 2021;77:109822. [PMID: 33152440 DOI: 10.1016/j.cellsig.2020.109822] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Fontanil T, Mohamedi Y, Espina-Casado J, Obaya ÁJ, Cobo T, Cal S. Hyalectanase Activities by the ADAMTS Metalloproteases. Int J Mol Sci 2021;22:2988. [PMID: 33804223 DOI: 10.3390/ijms22062988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Furini S, Falciani C. Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer. Front Oncol 2021;11:695858. [PMID: 34249755 DOI: 10.3389/fonc.2021.695858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Karamanos NK, Piperigkou Z, Passi A, Götte M, Rousselle P, Vlodavsky I. Extracellular matrix-based cancer targeting. Trends Mol Med 2021:S1471-4914(21)00190-8. [PMID: 34389240 DOI: 10.1016/j.molmed.2021.07.009] [Reference Citation Analysis]
4 Marques C, Reis CA, Vivès RR, Magalhães A. Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression. Front Oncol 2021;11:778752. [PMID: 34858858 DOI: 10.3389/fonc.2021.778752] [Reference Citation Analysis]
5 Keller-Pinter A, Gyulai-Nagy S, Becsky D, Dux L, Rovo L. Syndecan-4 in Tumor Cell Motility. Cancers (Basel) 2021;13:3322. [PMID: 34282767 DOI: 10.3390/cancers13133322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nassar E, Hassan N, El-Ghonaimy EA, Hassan H, Abdullah MS, Rottke TV, Kiesel L, Greve B, Ibrahim SA, Götte M. Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes. Cancers (Basel) 2021;13:2318. [PMID: 34066023 DOI: 10.3390/cancers13102318] [Reference Citation Analysis]
7 Ornitz DM, Itoh N. New developments in the biology of fibroblast growth factors. WIREs Mech Dis 2022;:e1549. [PMID: 35142107 DOI: 10.1002/wsbm.1549] [Reference Citation Analysis]
8 Paiardi G, Milanesi M, Wade RC, D'Ursi P, Rusnati M. A Bittersweet Computational Journey among Glycosaminoglycans. Biomolecules 2021;11:739. [PMID: 34063530 DOI: 10.3390/biom11050739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Grillo PK, Győrffy B, Götte M. Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients. J Cancer Res Clin Oncol 2021;147:1937-55. [PMID: 33742285 DOI: 10.1007/s00432-021-03597-4] [Reference Citation Analysis]
10 Shin WR, Park DY, Kim JH, Lee JP, Thai NQ, Oh IH, Sekhon SS, Choi W, Kim SY, Cho BK, Kim SC, Min J, Ahn JY, Kim YH. Structure based innovative approach to analyze aptaprobe-GPC3 complexes in hepatocellular carcinoma. J Nanobiotechnology 2022;20:204. [PMID: 35477501 DOI: 10.1186/s12951-022-01391-z] [Reference Citation Analysis]
11 Niland S, Eble JA. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment. Int J Mol Sci 2020;22:E238. [PMID: 33379400 DOI: 10.3390/ijms22010238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Wu X, Kang M, Wang D, Zhu M, Hu Y, Zhang Y, Deng C, Chen J, Teng L. Heparan sulfate analogues regulate tumor-derived exosome formation that attenuates exosome functions in tumor processes. Int J Biol Macromol 2021;187:481-91. [PMID: 34298051 DOI: 10.1016/j.ijbiomac.2021.07.110] [Reference Citation Analysis]
13 De Zutter A, Crijns H, Berghmans N, García-Caballero M, Vanbrabant L, Pörtner N, Vanheule V, Verscheure P, Siddiquei MM, Abu El-Asrar AM, Carmeliet P, Van Wielendaele P, De Meester I, Van Damme J, Proost P, Struyf S. The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors. Cancers (Basel) 2021;13:5090. [PMID: 34680238 DOI: 10.3390/cancers13205090] [Reference Citation Analysis]
14 Valla S, Hassan N, Vitale DL, Madanes D, Spinelli FM, Teixeira FCOB, Greve B, Espinoza-Sánchez NA, Cristina C, Alaniz L, Götte M. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells. Int J Mol Sci 2021;22:5874. [PMID: 34070901 DOI: 10.3390/ijms22115874] [Reference Citation Analysis]
15 Blum BC, Lin W, Lawton ML, Liu Q, Kwan J, Turcinovic I, Hekman R, Hu P, Emili A. Multi-Omic Metabolic Enrichment Network Analysis reveals metabolite-protein physical interaction subnetworks altered in cancer. Mol Cell Proteomics 2021;:100189. [PMID: 34933084 DOI: 10.1016/j.mcpro.2021.100189] [Reference Citation Analysis]
16 Hayes AJ, Melrose J. What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype. Int J Mol Sci 2021;22:4415. [PMID: 33922532 DOI: 10.3390/ijms22094415] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Guryanov I, Tennikova T, Urtti A. Peptide Inhibitors of Vascular Endothelial Growth Factor A: Current Situation and Perspectives. Pharmaceutics 2021;13:1337. [PMID: 34575413 DOI: 10.3390/pharmaceutics13091337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 De Pasquale V, Quiccione MS, Tafuri S, Avallone L, Pavone LM. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2. Int J Mol Sci 2021;22:6574. [PMID: 34207476 DOI: 10.3390/ijms22126574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Hillemeyer L, Espinoza-sanchez NA, Greve B, Hassan N, Chelariu-raicu A, Kiesel L, Götte M. The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis. IJMS 2022;23:5793. [DOI: 10.3390/ijms23105793] [Reference Citation Analysis]
20 Hu Y, Tao R, Chen L, Xiong Y, Xue H, Hu L, Yan C, Xie X, Lin Z, Panayi AC, Mi B, Liu G. Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis. J Nanobiotechnology 2021;19:150. [PMID: 34020670 DOI: 10.1186/s12951-021-00894-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Onyeisi JOS, Lopes CC, Götte M. Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer. Biomolecules 2021;11:503. [PMID: 33810567 DOI: 10.3390/biom11040503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Faria-Ramos I, Poças J, Marques C, Santos-Antunes J, Macedo G, Reis CA, Magalhães A. Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management. Biomolecules 2021;11:136. [PMID: 33494442 DOI: 10.3390/biom11020136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]